Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Kristyna Doleckova"'
Autor:
Petra Nytrova, Dominika Stastna, Adam Tesar, Ingrid Menkyova, Helena Posova, Helena Koprivova, Veronika Mikulova, Jiri Hrdy, Gabriela Smela, Dana Horakova, Irena Rysankova, Kristyna Doleckova, Michaela Tyblova
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
BackgroundRituximab (RTX) and ocrelizumab (OCR), B cell-depleting therapy targeting CD20 molecules, affect the humoral immune response after vaccination. How these therapies influence T-cell-mediated immune response against SARS-CoV-2 after immunizat
Externí odkaz:
https://doaj.org/article/fd83e3caa4d14846b4d386ffddd286ce
Autor:
Kristyna, Doleckova, Jan, Roth, Julia, Stellmachova, Tomas, Gescheidt, Vladimir, Sigut, Pavel, Houska, Robert, Jech, Michael, Zech, Martin, Vyhnalek, Emilie, Vyhnalkova, Pavel, Seeman, Anna Uhrova, Meszarosova
Publikováno v:
Neurological Research. 44:379-389
SPG11 is one of the most frequent autosomal recessively inherited types of hereditary spastic paraplegias (HSP or SPG). We describe the first seven patients from the Czech Republic with biallelic pathogenic variants in the SPG11. The typical HSP neur
Autor:
Hanadi Ananbeh, Jaromir Novak, Stefan Juhas, Jana Juhasova, Jiri Klempir, Kristyna Doleckova, Irena Rysankova, Karolina Turnovcova, Jaroslav Hanus, Hana Hansikova, Petr Vodicka, Helena Kupcova Skalnikova
Publikováno v:
International Journal of Molecular Sciences; Volume 23; Issue 10; Pages: 5598
(1) Background: Huntington’s disease (HD) is rare incurable hereditary neurodegenerative disorder caused by CAG repeat expansion in the gene coding for the protein huntingtin (HTT). Mutated huntingtin (mHTT) undergoes fragmentation and accumulation
Publikováno v:
Clinical care and clinical services.
Unintended weight loss is a negative prognostic factor in Huntington’s disease (HD). Exact mechanism of weight loss and influence of therapeutic intervention on this symptom is still unclear. In Prague centre Registry database containing 309 examin
Publikováno v:
Clinical care and clinical services.
The potentional benefit of symptomatic treatment of motor impairment in Huntington´s disease (HD) is still discussed. The aim of this study was to find out the effect of medication at different stages of this disease, In our Registry database contai
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Jakubikova, Michala, Tyblova, Michaela, Tesar, Adam, Magda, Horakova, Daniela, Vlazna, Irena, Rysankova, Iveta, Novakova, Kristyna, Doleckova, Pavel, Dusek, Jiri, Pitha, Stanislav, Vohanka, Josef, Bednarik
Publikováno v:
European Journal of Neurology; Jan2022, Vol. 29 Issue 1, pe7-e8, 2p